Clinical guides
Focused explainers distinguish what is being discussed from what is established, including a careful look at how long ibogaine effects may last in relation to a much broader treatment conversation.
Independent information resource
Services
Clear, evidence-aware guides for people considering questions about ibogaine and methadone dependence—built around uncertainty, serious cardiac risks, and the need to keep established treatment options in view.
A clinical brief, made usable
Information that keeps the stakes visible
Mavora offers informational tools, not medical services. The starting point is the clinical brief on ibogaine for methadone addiction, which separates investigational interest from claims of proven treatment and keeps risk language plainspoken.
Our scope and methods are described on the Mavora mission and information standards page. The goal is to help readers identify useful questions, understand what remains uncertain, and recognize where professional assessment matters.
Information offerings
A practical route through a complicated topic
Risk frameworks
Plain-language decision frameworks foreground medication interactions, screening questions, and why cardiac concerns are not a minor footnote. The FDA’s methadone safety communication describes potentially life-threatening heart-rhythm changes associated with methadone use.
Comparisons & context
Comparisons place ibogaine questions alongside established approaches to opioid use disorder without presenting an investigational substance as a replacement for care. We also clarify other names used for ibogaine so terminology does not obscure the underlying subject.
Research summaries
Research summaries explain the limits of available evidence and avoid turning early or selective findings into guarantees. Readers can examine discussions of reported ibogaine treatment success rates with the caution that outcomes, definitions, and follow-up vary.
Evidence in context
Terms, claims, and limits deserve room
Our glossary-style material helps readers separate pharmacology from marketing. For example, ibogaine’s general reference overview identifies it as a psychoactive compound, while questions about use in methadone dependence demand a much narrower and more cautious evidence discussion.
We also cover focused topics such as cognition-related questions around ibogaine, without treating subjective reports as clinical proof or overlooking safety implications.
“A useful resource makes uncertainty easier to see—not easier to ignore.”
How the resource is used
Three ways to orient a difficult decision
These are information services for affected people, supporters, and professionals seeking careful context. They do not replace assessment, diagnosis, monitoring, or treatment planning.
“Start with what is known, then name what is not.”
Evidence summaries identify gaps, small studies, and limits in extrapolating from individual accounts.
“Put cardiac safety before a story of rapid change.”
Risk-focused materials point to interaction questions and the importance of medically qualified evaluation.
“Keep established care visible in every comparison.”
Contextual guides explain why medication changes and transitions should not be simplified into one-size-fits-all pathways.
Common questions
Useful boundaries
Does Mavora provide ibogaine treatment?
No. Mavora is an independent information resource, not a clinic, medical provider, or licensed treatment center. It does not arrange treatment, offer individualized medical advice, or endorse providers such as an ibogaine treatment clinic in Mexico.
Why is cardiac risk emphasized?
Ibogaine has been associated with QT prolongation and potentially dangerous arrhythmias. Methadone can also affect cardiac electrical activity, making interaction and transition questions consequential. The National Institute on Drug Abuse overview of treatment approaches also notes that effective care can involve medication and behavioral treatment rather than a single intervention.
What else can readers compare?
Readers can use the resource to compare claims, terminology, and treatment narratives, including discussion of ibogaine and Rugby-related searches that may surface in broader online research. Context matters: a search result is not evidence of safety or suitability.
Begin with careful context, not a promise.
Explore the evidence-aware material designed to keep serious risks, uncertainty, and established treatment options in the frame.